
Diabetes
It is estimated that 4.4 million people live with diabetes mellitus in the UK and this number is expected to rise. Around 90% of people with diabetes have type 2 diabetes mellitus, while 8% have type 1 diabetes mellitus, with rarer diabetes types accounting for the final 2%.
Management of all diabetes types is likely to involve a combination of lifestyle advice and pharmacological management, involving insulin and other diabetes medications. Improperly managed diabetes can lead to significant morbidity and can even be fatal. Pharmacists working in all sectors are increasingly likely to encounter people with diabetes and should be able to recognise red-flag symptoms of diabetes complications and provide best practice medicines advice to ensure that patient’s condition is appropriately managed and that they are getting the most from their medication regimens.
If you have further topics that you would like to see included in the diabetes collection, please contact the research and learning team.
Diagnosis and management


Optimising use of SGLT2 inhibitors in hospital patients

Test your knowledge of diabetes

Perioperative management of type 2 diabetes mellitus

Insulin in practice for people with type 2 diabetes mellitus

Diagnosis and management of type 2 diabetes mellitus

Updated NICE guidance for type 2 diabetes: what do you need to know?
Complications

Test your knowledge of diabetes

Diabetic ketoacidosis in adults: identification, diagnosis and management

Acute complications of diabetes in adults: diagnosis and management

The diabetic foot
Supported contentLiving with diabetes

Test your knowledge of diabetes

Emotional wellbeing in children and young people with diabetes

Diabetes: mental health considerations in adults

Reversing type 2 diabetes: how pharmacists are helping patients to go drug-free

Managing diabetes in women during preconception and pregnancy
Research and future directions

Test your knowledge of diabetes

‘Beyond weight loss’: what is the future of semaglutide?

Digital therapeutics: integration in practice

The use of insulin biobetters and biosimilars in the UK

Celebrating 100 years of insulin

Diabetes in hospital: could more specialist pharmacists reduce high error rates?

Evaluating pharmacist interventions using the Simpler tool in Malaysian patients with type 2 diabetes
News and analysis

Fewer than 20% of type 2 diabetes patients on most effective medicine for them, model shows

ICBs may commission community pharmacies to offer diabetic eye screenings from 2026, says NHS England

GPs raise confidentiality and safety concerns about online prescribing of weight-loss drugs

MHRA warns of pulmonary aspiration risk for GLP-1 receptor agonists during general anaesthesia or deep sedation

EMA safety committee to review link between semaglutide and rare eye condition

Weight-loss drug use linked to reduced risk of substance misuse, study shows
